Clinical trial

Drone Biological Samples Transport Evaluation Compared to Walking in CHU CAEN NORMANDIE

Name
22-0238
Description
The transport of biological samples is a key step in the pre-analysis process in health facilities and must meet quality requirements (NF:EN:ISO 151989) to ensure that samples are transported in are transported in good conditions. Still in the experimental stage, drone-based air transport is participating in the aeronautical revolution of the development of unmanned aircraft on board in all areas of society, including health. This first project, led by the Biology Centre and the INNOVABIO Biological Resources Centre of the CHU de CAEN in collaboration with the company Delivrone, will allow to evaluate the feasibility in real condition of the mode of transport by drone versus transport of reference on the quality of a varied panel of medical biology examinations (biochemistry, hematology and haemostasis), on the safety of people (potentially infectious samples), on the control of the delivery time, on the control of the transport temperature (15-25°C ). The samples will be taken on 30 healthy volunteers with a total panel of 23 blood tests performed.
Trial arms
Trial start
2023-04-27
Estimated PCD
2023-08-27
Trial end
2023-08-30
Status
Completed
Treatment
Biological samples transport and analysis
Biological samples transport and analysis
Arms:
Drone transport, Pedestrian transport
Size
30
Primary endpoint
Impact on Sodium test
1 day
Impact on Potassium test
1 day
Impact on Chlorure test
1 day
Impact on Bicarbonate test
1 day
Impact on Protein test
1 day
Impact on Calcium test
1 day
Impact on Creatinin test
1 day
Impact on Urea test
1 day
Impact on Albumin test
1 day
Impact on Bilirubin test
1 day
Impact on liver transaminase (ALT) test
1 day
Impact on liver transaminase (AST) test
1 day
Impact on alkalin phosphatase test
1 day
Impact on GGT test
1 day
Impact on LDH test
1 day
Impact on C-reactive Protein test
1 day
Impact on red blood cells count
1 day
Impact on hemoglobin test
1 day
Impact on white blood cells count
1 day
Impact on neutrophil cells count
1 day
Impact on lymphocytes cells count
1 day
Impact on platelets count
1 day
Impact on sedimentation rate test
1 day
Impact on PT test
1 day
Impact on a-PTT test
1 day
Impact on Fibrinogen test
1 day
Impact on D-Dimer test
1 day
Eligibility criteria
Inclusion Criteria: * Healthy volunteers, over 18 years old Exclusion Criteria: * Unhealthy volunteers previously known * pregnant or breastfeeding woman
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'bioSpec': {'retention': 'SAMPLES_WITHOUT_DNA', 'description': 'blood'}, 'enrollmentInfo': {'count': 30, 'type': 'ACTUAL'}}
Updated at
2024-03-05

1 organization

1 product

1 indication

Indication
Healthy